source
- Personalized mRNA melanoma vaccine shows clinical success, reviving optimism for the platformModerna and Merck reported positive results from a personalized mRNA vaccine designed to treat melanoma in a recent clinical study. The outcome is being hailed as a boost for mRNA technology, whic…
- Experts urge FDA to boost transparency of complete response letters and refine master protocol guidanceA recent paper in the Journal of Law and the Biosciences outlines ways the FDA could better disclose complete response letters to the public, aiming to increase transparency for stakeholders. Indu…